200 related articles for article (PubMed ID: 38253690)
21. N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children.
Wright S; Hacohen Y; Jacobson L; Agrawal S; Gupta R; Philip S; Smith M; Lim M; Wassmer E; Vincent A
Arch Dis Child; 2015 Jun; 100(6):521-6. PubMed ID: 25637141
[TBL] [Abstract][Full Text] [Related]
22. CSF reactivity in GABA
Nikolaus M; Kreye J; Turko P; Vida I; Knierim E; Prüss H
Brain Res; 2019 Feb; 1704():249-256. PubMed ID: 30347219
[TBL] [Abstract][Full Text] [Related]
23. Long-term α5 GABA A receptor negative allosteric modulator treatment reduces NMDAR-mediated neuronal excitation and maintains basal neuronal inhibition.
Nuwer JL; Povysheva N; Jacob TC
Neuropharmacology; 2023 Oct; 237():109587. PubMed ID: 37270156
[TBL] [Abstract][Full Text] [Related]
24. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
[No Abstract] [Full Text] [Related]
25. BDNF shifts excitatory-inhibitory balance in the paraventricular nucleus of the hypothalamus to elevate blood pressure.
Thorsdottir D; Einwag Z; Erdos B
J Neurophysiol; 2021 Oct; 126(4):1209-1220. PubMed ID: 34406887
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune channelopathies in paraneoplastic neurological syndromes.
Joubert B; Honnorat J
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2665-76. PubMed ID: 25883091
[TBL] [Abstract][Full Text] [Related]
27. N-methyl-D-aspartate receptor encephalitis: laboratory diagnostics and comparative clinical features in adults and children.
Gastaldi M; Nosadini M; Spatola M; Sartori S; Franciotta D
Expert Rev Mol Diagn; 2018 Feb; 18(2):181-193. PubMed ID: 29376438
[TBL] [Abstract][Full Text] [Related]
28. Recurrent anti-NMDAR encephalitis during pregnancy combined with two antibodies positive.
Liu H; Chen X
Arch Womens Ment Health; 2021 Dec; 24(6):1045-1050. PubMed ID: 33835270
[TBL] [Abstract][Full Text] [Related]
29. Anti-NMDAR autoimmune encephalitis.
Miya K; Takahashi Y; Mori H
Brain Dev; 2014 Sep; 36(8):645-52. PubMed ID: 24211006
[TBL] [Abstract][Full Text] [Related]
30. An Assay to Determine Mechanisms of Rapid Autoantibody-Induced Neurotransmitter Receptor Endocytosis and Vesicular Trafficking in Autoimmune Encephalitis.
Amedonu E; Brenker C; Barman S; Schreiber JA; Becker S; Peischard S; Strutz-Seebohm N; Strippel C; Dik A; Hartung HP; Budde T; Wiendl H; Strünker T; Wünsch B; Goebels N; Meuth SG; Seebohm G; Melzer N
Front Neurol; 2019; 10():178. PubMed ID: 30881339
[TBL] [Abstract][Full Text] [Related]
31. Differential Modes of Action of α1- and α1γ2-Autoantibodies Derived from Patients with GABA
van Casteren ACM; Ackermann F; Rahman KA; Andrzejak E; Rosenmund C; Kreye J; Prüss H; Garner CC; Ichkova A
eNeuro; 2022; 9(6):. PubMed ID: 36446572
[TBL] [Abstract][Full Text] [Related]
32. Autoimmune NMDA receptor encephalitis.
Lazar-Molnar E; Tebo AE
Clin Chim Acta; 2015 Jan; 438():90-7. PubMed ID: 25149104
[TBL] [Abstract][Full Text] [Related]
33. [Autoimmune encephalitis-update: roles of autoantibodies in the pathogenesis].
Tanaka K
Rinsho Shinkeigaku; 2014; 54(12):1107-9. PubMed ID: 25672721
[TBL] [Abstract][Full Text] [Related]
34. Refractory status epilepticus and autoimmune encephalitis with GABAAR and GAD65 antibodies: A case report.
Gagnon MM; Savard M; Mourabit Amari K
Seizure; 2016 Apr; 37():25-7. PubMed ID: 26921483
[TBL] [Abstract][Full Text] [Related]
35. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.
Armangue T; Spatola M; Vlagea A; Mattozzi S; Cárceles-Cordon M; Martinez-Heras E; Llufriu S; Muchart J; Erro ME; Abraira L; Moris G; Monros-Giménez L; Corral-Corral Í; Montejo C; Toledo M; Bataller L; Secondi G; Ariño H; Martínez-Hernández E; Juan M; Marcos MA; Alsina L; Saiz A; Rosenfeld MR; Graus F; Dalmau J;
Lancet Neurol; 2018 Sep; 17(9):760-772. PubMed ID: 30049614
[TBL] [Abstract][Full Text] [Related]
36. Clinical variables that help in predicting the presence of autoantibodies in patients with acute encephalitis.
Lizcano-Meneses A; Watanabe N; von Glehn F; Barbosa R; de Albuquerque M; Yassuda C; Moraes AS; Martínez JW; Santos LMB; Cendes F
Seizure; 2021 Aug; 90():117-122. PubMed ID: 33658153
[TBL] [Abstract][Full Text] [Related]
37. Risk Factors for Mortality in Anti-NMDAR, Anti-LGI1, and Anti-GABABR Encephalitis.
Zhong R; Chen Q; Zhang X; Zhang H; Lin W
Front Immunol; 2022; 13():845365. PubMed ID: 35320933
[TBL] [Abstract][Full Text] [Related]
38. Practical issues in measuring autoantibodies to neuronal cell-surface antigens in autoimmune neurological disorders: 190 cases.
Kaneko J; Kanazawa N; Tominaga N; Kaneko A; Suga H; Usui R; Ishima D; Kitamura E; Akutsu T; Yoshida K; Nishiyama K; Iizuka T
J Neurol Sci; 2018 Jul; 390():26-32. PubMed ID: 29801900
[TBL] [Abstract][Full Text] [Related]
39. [Interactions between dopamine receptor and NMDA/type A γ-aminobutyric acid receptors].
Chen HY; Wei TJ; Weng JJ; Qin JY; Huang X; Su JP
Sheng Li Xue Bao; 2016 Apr; 68(2):185-93. PubMed ID: 27108906
[TBL] [Abstract][Full Text] [Related]
40. Single-nucleus RNA sequencing unveils critical regulators in various hippocampal neurons for anti-N-methyl-D-aspartate receptor encephalitis.
Bai Y; Liu Z; Qian T; Peng Y; Ma H; Hu H; Cheng G; Wen H; Xie L; Zheng D; Geng Q; Wang J; Wang H
Brain Pathol; 2023 Jul; 33(4):e13156. PubMed ID: 36942475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
